Dana L E Vergoossen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Myasthenia Gravis

Systemic Lupus Erythematosus

Tyrosine Kinase

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

The European journal of neuroscience

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Oury, Begona Gamallo-Lana, Leah Santana, Christophe Steyaert, Dana L E Vergoossen, Adam C Mar, Bernhardt Vankerckhoven, Karen Silence, Roeland Vanhauwaert, Maartje G Huijbers, Steven J Burden
Agonist antibody to MuSK protects mice from MuSK myasthenia gravis. Proceedings of the National Academy of Sciences of the United States of America 121 (39) (2024)
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, Christophe Steyaert, Stine Marie Jensen, Dana L E Vergoossen, Christa Kneip, Leah Santana, Jamie L Lim, Jaap J Plomp, Roy Augustinus, Shohei Koide, Christophe Blanchetot, Peter Ulrichts, Maartje G Huijbers, Karen Silence, Steven J Burden
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome. Science translational medicine 16 (765) (2024)
Dana L E Vergoossen, Arlin Keo, Ahmed Mahfouz, Maartje G Huijbers
Timing and localization of myasthenia gravis-related gene expression. The European journal of neuroscience 54 (4) (2021)